Reply to the Letter to the Editor ‘There is no place for ovarian cancer screening in hereditary breast–ovarian cancer syndromes (in regard to “ESMO Clinical Practice Guideline on risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes”)’ by W. Tjalma
